Literature DB >> 7852587

Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype.

K Irifune1, T Ishida, K Shimoguchi, J Ohtake, T Tanaka, N Morikawa, M Kaku, H Koga, S Kohno, K Hara.   

Abstract

We describe the first known case of pneumonia caused by a mucoid Stenotrophomonas maltophilia (Xanthomonas maltophilia) strain in a patient with bronchiectasis. The patient was admitted because of mild hemoptysis and productive cough with infiltrative shadow in the right lower lung field on chest X ray. The clinical symptoms were mild, and treatment with minocycline was effective.

Entities:  

Mesh：

Year:  1994        PMID： 7852587      PMCID： PMC264175          DOI： 10.1128/jcm.32.11.2856-2857.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  3 in total

1.  Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature.

Authors:  J J Zuravleff; V L Yu
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

2.  Primary Pseudomonas maltophilia infection of the lung.

Authors:  T K Sarkar; G Gilardi; A S Aguam; J Josephson; G L Leventhal
Journal:  Postgrad Med       Date:  1979-02       Impact factor: 3.840

3.  Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983.

Authors:  N J Palleroni; J F Bradbury
Journal:  Int J Syst Bacteriol       Date:  1993-07
  3 in total
  6 in total

1.  Pseudo-, Xantho-, and now Stenotrophomonas maltophilia: New kid on the block.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1996-03

Review 2.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.

Authors:  María Dolores Navarro-Martínez; Enma Navarro-Perán; Juan Cabezas-Herrera; Joaquín Ruiz-Gómez; Francisco García-Cánovas; José Neptuno Rodríguez-López
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 4.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

Review 5.  Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review.

Authors:  Kazuhiro Ishikawa; Tomoaki Nakamura; Fujimi Kawai; Yuki Uehara; Nobuyoshi Mori
Journal:  Am J Case Rep       Date:  2022-07-19

Review 6.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.